Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract.

MLA

Ohtsuka, Yukihiro, et al. “Loss of Uroplakin III Expression Is Associated with a Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Urinary Tract.” BJU International, vol. 97, no. 6, June 2006, pp. 1322–26. EBSCOhost, https://doi.org/10.1111/j.1464-410X.2006.06158.x.

APA

Ohtsuka, Y., Kawakami, S., Fujii, Y., Koga, F., Saito, K., Ando, N., Takizawa, T., Kageyama, Y., & Kihara, K. (2006). Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract. BJU International, 97(6), 1322–1326. https://doi.org/10.1111/j.1464-410X.2006.06158.x

Chicago

Ohtsuka, Yukihiro, Satoru Kawakami, Yasuhisa Fujii, Fumitaka Koga, Kazutaka Saito, Noboru Ando, Touichiro Takizawa, Yukio Kageyama, and Kazunori Kihara. 2006. “Loss of Uroplakin III Expression Is Associated with a Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Urinary Tract.” BJU International 97 (6): 1322–26. doi:10.1111/j.1464-410X.2006.06158.x.